Prescription drug abuse in Canada and the diversion of prescription drugs into the illicit drug market

被引:37
|
作者
Haydon, E
Rehm, J
Fischer, B
Monga, N
Adlaf, E
机构
[1] Ctr Addict & Mental Hlth, Toronto, ON M5S 2S1, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Res Inst Addict, Zurich, Switzerland
关键词
prescriptions; drug; Canada; adolescents; drugs of abuse;
D O I
10.1007/BF03405190
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Prescription drug abuse has received considerable attention in media reports in recent years. The purpose of this article is to describe the Canadian situation and context with regards to prescription drug abuse and the diversion of psychotropic prescription drugs into the illicit drug market, with a focus on the need for more data and interventions. Canada ranks within the top 10% of countries in the use of benzodiazepines, opioid prescriptions and stimulants. There are many ways that prescription drugs are diverted into the illicit market and varied reasons for use and abuse. Prescription drug abuse is further related to a number of negative consequences, including overdose. While seniors and women have been the primary focus for research in Canada on prescription drug abuse, adolescents and young adults have received less attention. Systematic epidemiological data specifically on prescription drug abuse in the Canada context are lacking and are needed in order to more clearly understand the reasons for the phenomenon and to develop and implement appropriate interventions.
引用
收藏
页码:459 / 461
页数:3
相关论文
共 50 条
  • [1] Prescription Drug Abuse in Canada and the Diversion of Prescription Drugs into the Illicit Drug Market
    Emma Haydon
    Jürgen Rehm
    Benedikt Fischer
    Neerav Monga
    Edward Adlaf
    [J]. Canadian Journal of Public Health, 2005, 96 : 459 - 461
  • [2] PRESCRIPTION DRUG MISUSE, ABUSE AND DIVERSION
    CLYMER, JT
    [J]. ARIZONA MEDICINE, 1981, 38 (01) : 46 - 47
  • [3] Prescription Compliance or Illicit Designer Drug Abuse?
    Petrie, Matthew S.
    Lynch, Kara L.
    Wu, Alan H. B.
    Steinhardt, Angela A.
    Horowitz, Gary L.
    [J]. CLINICAL CHEMISTRY, 2012, 58 (12) : 1631 - 1634
  • [4] Prescription Compliance or Illicit Designer Drug Abuse? Commentary
    Ganetsky, Michael
    [J]. CLINICAL CHEMISTRY, 2012, 58 (12) : 1634 - 1635
  • [5] Do prescription drug monitoring programs encourage prescription - or illicit - opioid abuse?
    Meadowcroft, Devon
    Whitacre, Brian
    [J]. SUBSTANCE ABUSE, 2021, 42 (01) : 65 - 75
  • [6] PRESCRIPTION DRUG ABUSE & DIVERSION: ROLE OF THE PAIN CLINIC
    Rigg, Khary K.
    March, Samantha J.
    Inciardi, James A.
    [J]. JOURNAL OF DRUG ISSUES, 2010, 40 (03) : 681 - 701
  • [7] Drugs on Saturday to combat "Prescription drug abuse"
    Sivagnanam, G.
    [J]. JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2011, 2 (03) : 217 - U141
  • [8] GLOBAL PERSPECTIVE ON PRESCRIPTION DRUG ABUSE AND DIVERSION, STRATEGIES TO CURB THE ABUSE
    Alho, H.
    [J]. ALCOHOL AND ALCOHOLISM, 2014, 49
  • [9] Illicit and prescription drug misuse as reported to the Maine Diversion Alert Program
    Piper, Brian J.
    Suarez, Michael J.
    Piserchio, John P.
    Shah, Dipam T.
    Simoyan, Olapeju M.
    McCall, Kenneth L.
    Desrosiers, Clare E.
    Nichols, Stephanie D.
    [J]. FORENSIC SCIENCE INTERNATIONAL, 2018, 285 : 65 - 71
  • [10] Prescription Drug Abuse
    Retan, J. Walden
    [J]. ANNALS OF INTERNAL MEDICINE, 2014, 161 (04) : 305 - 306